Madeleine Farman
Madeleine Farman is a senior reporter for PEI Group’s Private Equity International and Secondaries Investor titles, based in London. Prior to joining PEI, she had covered private equity, private capital and advisers associated with the industry for other newsrooms and publications since 2016. Originally from New Zealand, Madeleine began her career in radio in Auckland.
Rabo Investments also invested in the deal centred on vitamin, mineral and supplement soft gel manufacturer Captek Softgel International.
The level of dry powder for secondaries sits at $94bn, up year-on-year and a slight decrease from the $105bn available for deployment at the end of 2021, according to Evercore's H1 Secondary Market report.
The New York-headquartered firm surpassed its $2bn target for Pomona Capital X, which is 44% larger than its predecessor.
A raft of new participants in the sector means it may not be long before annual deal volumes match or exceed the record $130bn deployed last year.
Experts from Greenhill, NewQuest and LGT Capital Partners discuss what’s driving secondaries dealflow in Asia-Pacific this year.
With the launch of S3, Apollo becomes 'much more of a one-stop relationship' for GPs, co-president Scott Kleinman tells Secondaries Investor.
Capital raised for secondaries fell 30% to $31.2bn in the first half of 2022, according to data compiled by Secondaries Investor.
Robert Emerson joins from Kirkland & Ellis, where his clients included Whitehorse Liquidity Partners, Vista Equity Partners and Two Sigma.
Buyers are showing greater manager selectivity but are willing to pay for quality, a Palico spokesperson said.
At more than double the size of its predecessor, Banner Ridge DSCO Fund II will invest in private equity funds, co-investments and early secondaries.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: